Dow Up 0.51% Nasdaq Up 0.24%

Ocera Therapeutics, Inc. (OCRX)

-NasdaqGM
5.81 Up 0.50(9.42%) Nov 21, 4:00PM EST
Prev Close:5.31
Open:5.40
Bid:N/A
Ask:6.81 x 1000
1y Target Est:17.00
Beta:3.5
Next Earnings Date:N/A
Day's Range:5.35 - 6.22
52wk Range:4.47 - 19.94
Volume:154,431
Avg Vol (3m):32,406
Market Cap:114.70M
P/E (ttm):N/A
EPS (ttm):-1.92
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OCRX

Comparison

Symbol% ChgMkt Cap
OCRXUp 9.42%114.70M
IRWDUp 1.24%1.93B
THRXDown 0.29%1.61B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):288.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.56
Quarterly EPS Est (Dec-14) :-0.45
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ocera Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the development and commercialization of OCR-002, which is in Phase IIb trials for the treatment of hepatic encephalopathy in patients with liver cirrho... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback